EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,430 | -5.2% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15,229 | +13.5% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,414 | +688.1% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,702 | -99.9% | 1,850 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,468,000 | -39.3% | 1,850 | -14.0% | 0.01% | -33.3% |
| Q2 2022 | $4,067,000 | -0.3% | 2,150 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $4,081,000 | -49.2% | 2,150 | 0.0% | 0.01% | -50.0% |
| Q4 2021 | $8,033,000 | -0.4% | 2,150 | 0.0% | 0.02% | -5.3% |
| Q3 2021 | $8,062,000 | -53.0% | 2,150 | -37.7% | 0.02% | -52.5% |
| Q2 2021 | $17,170,000 | +34.8% | 3,450 | -5.5% | 0.04% | +17.6% |
| Q1 2021 | $12,740,000 | -40.1% | 3,650 | -2.7% | 0.03% | -41.4% |
| Q4 2020 | $21,274,000 | +7.9% | 3,750 | +7.1% | 0.06% | +544.4% |
| Q3 2020 | $19,720,000 | -5.2% | 3,500 | -2.8% | 0.01% | -25.0% |
| Q2 2020 | $20,791,000 | -80.5% | 3,600 | -75.5% | 0.01% | -83.6% |
| Q1 2020 | $106,394,000 | – | 14,688 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |